Literature DB >> 35465338

Ambulatory Duchenne muscular dystrophy children: cross-sectional correlation between function, quantitative muscle ultrasound and MRI.

Hala Abdulhady1, Hossam M Sakr2, Nermine S Elsayed3, Tamer A El-Sobky4, Nagia Fahmy5, Amr M Saadawy2, Heba Elsedfy3.   

Abstract

Duchenne muscular dystrophy (DMD) is a progressive genetic muscle disease. Quantitative muscle ultrasound (US), muscle MRI, and functional tools are important to delineate characteristics of muscle involvement. We aimed to establish correlations between clinical/functional and above-named imaging tools respecting their diagnostic and prognostic role in DMD children. A cross-sectional retrospective study of 27 steroid-naive, ambulant male children/adolescents with genetically-confirmed DMD (mean age, 8.8 ± 3.3 years). Functional performance was assessed using motor function measure (MFM) which assess standing/transfer (D1), proximal (D2) and distal (D3) motor function, and six-minute walk test (6MWT). Imaging evaluation included quantitative muscle MRI which measured muscle fat content in a specific location of right rectus femoris by mDixon sequence. Quantitative muscle US measured right rectus femoris muscle brightness in standardized US image as an indicator of muscle fat content. We found a highly significant positive correlation between the mean MFM total score and 6MWT (R = 0.537, p = 0.007), and a highly significant negative correlation between fat content by muscle US and MFM total score (R = -0.603, p = 0.006) and its D1 subscore (R =-0.712, p = 0.001), and a significant negative correlation between fat content by US and 6MWT (R = -0.529, p = 0.02), and a significant positive correlation between muscle fat content by mDixon MRI and patient's age (R = 0.617, p = 0.01). Quantitative muscle US correlates significantly with clinical/functional assessment tools as MFM and 6MWT, and augments their role in disease-tracking of DMD. Quantitative muscle US has the potential to act as a substitute to functional assessment tools. ©2022 Gaetano Conte Academy - Mediterranean Society of Myology.

Entities:  

Keywords:  6-minute walk test; dystrophinopathies; motor function measure; muscle ultrasonography; quantitative magnetic resonance imaging

Mesh:

Year:  2022        PMID: 35465338      PMCID: PMC9004336          DOI: 10.36185/2532-1900-063

Source DB:  PubMed          Journal:  Acta Myol        ISSN: 1128-2460


  42 in total

1.  ATS statement: guidelines for the six-minute walk test.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2002-07-01       Impact factor: 21.405

2.  Manual ability and upper limb performance in nonambulatory stage of Duchenne muscular dystrophy.

Authors:  G Demir; N Bulut; Ö Yılmaz; A Karaduman; İ Alemdaroğlu-Gürbüz
Journal:  Arch Pediatr       Date:  2020-07-24       Impact factor: 1.180

3.  Quantitative muscle ultrasound detects disease progression in Duchenne muscular dystrophy.

Authors:  Craig M Zaidman; Jim S Wu; Kush Kapur; Amy Pasternak; Lavanya Madabusi; Sung Yim; Adam Pacheck; Heather Szelag; Tim Harrington; Basil T Darras; Seward B Rutkove
Journal:  Ann Neurol       Date:  2017-05-04       Impact factor: 10.422

4.  Magnetic resonance imaging of the proximal upper extremity musculature in boys with Duchenne muscular dystrophy.

Authors:  R J Willcocks; W T Triplett; S C Forbes; H Arora; C R Senesac; D J Lott; T R Nicholson; W D Rooney; G A Walter; K Vandenborne
Journal:  J Neurol       Date:  2016-10-24       Impact factor: 4.849

5.  Muscle MRI in Duchenne muscular dystrophy: Evidence of a distinctive pattern.

Authors:  Kiran Polavarapu; Mahadevappa Manjunath; Veeramani Preethish-Kumar; Deepha Sekar; Seena Vengalil; PriyaTreesa Thomas; Talakad N Sathyaprabha; Rose Dawn Bharath; Atchayaram Nalini
Journal:  Neuromuscul Disord       Date:  2016-09-05       Impact factor: 4.296

6.  Frameshift deletions of exons 3-7 and revertant fibers in Duchenne muscular dystrophy: mechanisms of dystrophin production.

Authors:  A V Winnard; J R Mendell; T W Prior; J Florence; A H Burghes
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

7.  Recent developments in the treatment of Duchenne muscular dystrophy and spinal muscular atrophy.

Authors:  Wendy K M Liew; Peter B Kang
Journal:  Ther Adv Neurol Disord       Date:  2013-05       Impact factor: 6.570

Review 8.  The importance of genetic diagnosis for Duchenne muscular dystrophy.

Authors:  Annemieke Aartsma-Rus; Ieke B Ginjaar; Kate Bushby
Journal:  J Med Genet       Date:  2016-01-11       Impact factor: 6.318

9.  Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy.

Authors:  Diane E Frank; Frederick J Schnell; Cody Akana; Saleh H El-Husayni; Cody A Desjardins; Jennifer Morgan; Jay S Charleston; Valentina Sardone; Joana Domingos; George Dickson; Volker Straub; Michela Guglieri; Eugenio Mercuri; Laurent Servais; Francesco Muntoni
Journal:  Neurology       Date:  2020-03-05       Impact factor: 9.910

10.  MRI vastus lateralis fat fraction predicts loss of ambulation in Duchenne muscular dystrophy.

Authors:  Karin J Naarding; Harmen Reyngoudt; Erik W van Zwet; Melissa T Hooijmans; Cuixia Tian; Irina Rybalsky; Karen C Shellenbarger; Julien Le Louër; Brenda L Wong; Pierre G Carlier; Hermien E Kan; Erik H Niks
Journal:  Neurology       Date:  2020-01-14       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.